HR19042 Capsules

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Autoimmune HepatitisIgA Nephropathy

Phase 2

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.

CompletedNCT05016323

Jiangsu HengRui Medicine Co., Ltd.IgA Nephropathy

Start: 2021-09-09End: 2025-08-15Updated: 2026-03-12

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

CompletedNCT05476900

Jiangsu HengRui Medicine Co., Ltd.Autoimmune Hepatitis

Start: 2022-10-06End: 2025-03-14Updated: 2025-03-24